Information updates

Bee venom immunotherapy update

June 14, 2017:  

Following the previous communication earlier this year from Stallergenes Greer regarding the shortage of ALBEY honey bee venom 550mcg, the US/Canadian approved 550mcg-concentrated Hymenoptera honey bee venom freeze-dried powder has been authorised for supply under S19A (1), of the Therapeutic Goods Act as an alternative for Australian patients.

Therefore Hymenoptera 550mcg honey bee venom product can now be ordered as an alternative option for ALBEY honey bee Venom 550mcg.

The same PBS code 10621B will apply, which was previously used for Hymenoptera honey bee venom. PBS reimbursement will be effective from 1st July 2017. Any prescription written before 1st July will not be eligible for PBS subsidy. 

For more information go to www.allergy.org.au/members/allergen-immunotherapy-information 

 Content updated 14 June 2017